Sales are irrelevant. The sales revenue is from the limited people who have accessed the early access scheme. Sales at the moment are not the focus. The current aim is to expose the drug to users who can give usability feedback. Investors who believe the sales revenue is light on are missing the point.
The announcement gave great clarity about the next steps towards FDA approval and the awesome news is there are NO red flags !
$1b market value is on its way this year 10X prize for those who get it.
LTP Price at posting:
78.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)